SCHEMBL10831728

SCHEMBL10831728

CCc1noc(C)c1-c1[nH]c2ccc(F)cc2c1C(O)C(C)(C)N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
CSF1R P07333 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
KIF11 P52732 1/20 0.32
TLR9 Q9NR96 5/20 0.32
TLR8 Q9NR97 5/20 0.32
TLR7 Q9NYK1 5/20 0.32
BACE1 P56817 1/20 0.32
GABRA4 P48169 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10831599 0.90 BRD4 (0.35) BRD4BRD2BRD3NPC1RAB9A
SCHEMBL10951500 0.88 BRD4 (0.40) BRD4CSF1RHTR2AHTR2CGABRA1
SCHEMBL10832142 0.87 BRD4 (0.39) BRD4BRD2BRD3NPC1RAB9A
SCHEMBL10956077 0.84 BRD4 (0.34) BRD4BRD2BRD3CSF1RHTR2A
SCHEMBL10831731 0.82 TLR8 (0.34) BRD4BRD2BRD3CSF1RNPC1
SCHEMBL11089655 0.81 TLR9 (0.37) BRD4BRD2BRD3TLR9TLR8
SCHEMBL10950276 0.79 TLR9 (0.37) BRD4TLR9TLR8TLR7
SCHEMBL11079151 0.76 NPC1 (0.40) BRD4CSF1RNPC1RAB9AHTR2A
SCHEMBL10984221 0.74 NPC1 (0.39) BRD4BRD2BRD3CSF1RNPC1
SCHEMBL10831601 0.73 BRD4 (0.36) BRD4BRD2BRD3NPC1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4336379-A ANTIDIABETIC AGENTS SANDOZ, INC. (US) 1982-06-22 US claimed
US-4582848-A 2-substituted-3-indolamines and use thereof as anti-diabetics SANDOZ, INC. (US) 1986-04-15 US disclosed
US-4544663-A ASPERMATOGENESIS INDUCERS SANDOZ, INC. (US) 1985-10-01 US disclosed
US-4499279-A ANTIDIABETIC AND HYPOGLYCEMIC AGENTS SANDOZ, INC. (US) 1985-02-12 US disclosed
US-4419353-A ANTIDIABETIC AGENTS SANDOZ, INC. (US) 1983-12-06 US disclosed
US-4336379-A ANTIDIABETIC AGENTS SANDOZ, INC. (US) 1982-06-22 US disclosed